ArticleQuantitative imaging in medicine and surgery2026
Altered neurovascular coupling in patients with human immunodeficiency virus-associated asymptomatic neurocognitive impairment: a multimodal magnetic resonance imaging study.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Human immunodeficiency virus (HIV) infection can lead to HIV-associated neurocognitive disorders (HAND), among which asymptomatic neurocognitive impairment (ANI) represents a critical stage for early intervention. However, neuroimaging biomarkers with high sensitivity and specificity for ANI are lacking. The neurovascular coupling (NVC) characteristic in ANI remains unclear. This study aimed to investigate changes in cerebral blood flow (CBF), functional connectivity strength (FCS), and their coupling in patients with ANI under both resting-state and movie-watching conditions, and to evaluate the discriminative performance of multimodal neuroimaging indicators for ANI. Methods: This study enrolled 75 participants with HIV, including 41 with ANI and 34 who were cognitively normal (CN). All participants underwent multimodal magnetic resonance imaging (MRI), including T1-weighted imaging, arterial spin labeling (ASL), resting-state and movie-watching-state functional MRI (fMRI). CBF, FCS, and CBF-FCS coupling coefficients were calculated. Between-group differences were assessed using independent-samples t-tests, with adjustments for age and years of education, and multiple-comparison correction where applicable. Correlation analyses were conducted to explore their associations with cognitive and clinical indicators. Three machine learning (ML) models [K-Nearest Neighbors (KNN), Random Forest (RF), and Support Vector Machine (SVM)] with leave-one-out cross-validation were constructed to evaluate the classification performance of multimodal neuroimaging metrics for ANI, and SHapley Additive exPlanations (SHAP) were applied to quantify feature importance. Results: The ANI group exhibited abnormal CBF in multiple brain regions and abnormal FCS in both resting-state and movie-watching-state. At the whole-brain level, the CBF-FCS coupling reversed from weakly positive in the CN participants (resting-state: Conclusions: Patients with ANI exhibit abnormal CBF, FCS, and NVC. Compared with the resting-state paradigm, the movie paradigm was more sensitive in detecting neural functional abnormalities. The integration of multimodal neuroimaging indicators showed promising discriminative performance for ANI classification. NVC decoupling may represent a candidate neuroimaging marker of early ANI-related brain alterations and warrants longitudinal validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.